Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

0.7779
Delayed Data
As of Oct 18
 -0.0172 / -2.16%
Today’s Change
0.77
Today|||52-Week Range
1.47
-32.36%
Year-to-Date
No recent news for VIVUS Inc.

Today’s Trading

Previous close0.80
Today’s open0.81
Day’s range0.77 - 0.81
Volume712,246
Average volume (3 months)821,117
Market cap$84.2M
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-277.27%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+30.21%
P/E ratio2.5
Price/Sales0.97
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
GEMPGemphire Therapeutic...-0.08-0.83%
ALIMAlimera Sciences Inc+0.02+1.53%
MEIPMEI Pharma Inc+0.15+6.44%
ZFGNZafgen Inc+0.13+3.60%
Data as of 3:59pm ET, 10/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$124.3M
Annual profit (last year)$23.3M
Net profit margin18.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Campbell, California

Forecasts